TY - JOUR
T1 - Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
AU - Kinyoki, Damaris
AU - Osgood-Zimmerman, Aaron E.
AU - Bhattacharjee, Natalia V.
AU - Local Burden of Disease Anaemia Collaborators
AU - Accrombessi, Manfred Mario Kokou
AU - Kassebaum, Nicholas J.
AU - Hay, Simon I.
A2 - Schaeffer, Lauren E.
A2 - Lazzar-Atwood, Alice
A2 - Lu, Dan
A2 - Ewald, Samuel B.
A2 - Donkers, Katie M.
A2 - Letourneau, Ian D.
A2 - Collison, Michael
A2 - Schipp, Megan F.
A2 - Abajobir, Amanuel
A2 - Abbasi, Sima
A2 - Abbasi, Nooshin
A2 - Abbasifard, Mitra
A2 - Abbasi-Kangevari, Mohsen
A2 - Abbastabar, Hedayat
A2 - Abd-Allah, Foad
A2 - Abdelalim, Ahmed
A2 - Abd-Elsalam, Sherief M.
A2 - Abdoli, Amir
A2 - Abdollahpour, Ibrahim
A2 - Abedi, Aidin
A2 - Abolhassani, Hassan
A2 - Abraham, Biju
A2 - Abreu, Lucas Guimarães
A2 - Abrigo, Michael R.M.
A2 - Abualhasan, Ahmed
A2 - Abu-Gharbieh, Eman
A2 - Abushouk, Abdelrahman I.
A2 - Adabi, Maryam
A2 - Adebayo, Oladimeji M.
A2 - Adegbosin, Adeyinka Emmanuel
A2 - Adekanmbi, Victor
A2 - Adetokunboh, Olatunji O.
A2 - Adeyinka, Daniel Adedayo
A2 - Adham, Davoud
A2 - Advani, Shailesh M.
A2 - Agasthi, Pradyumna
A2 - Aghaali, Mohammad
A2 - Ahmad, Sohail
A2 - Ahmad, Tauseef
A2 - Ahmadi, Keivan
A2 - Ahmadi, Sepideh
A2 - Ahmed, Muktar Beshir
A2 - Aichour, Miloud Taki Eddine
A2 - Aji, Budi
A2 - Ghith, Nermin
A2 - Rezahosseini, Omid
A2 - Shamali, Mahdi
PY - 2021
Y1 - 2021
N2 - Anemia is a globally widespread condition in women and is associated with reduced economic productivity and increased mortality worldwide. Here we map annual 2000–2018 geospatial estimates of anemia prevalence in women of reproductive age (15–49 years) across 82 low- and middle-income countries (LMICs), stratify anemia by severity and aggregate results to policy-relevant administrative and national levels. Additionally, we provide subnational disparity analyses to provide a comprehensive overview of anemia prevalence inequalities within these countries and predict progress toward the World Health Organization’s Global Nutrition Target (WHO GNT) to reduce anemia by half by 2030. Our results demonstrate widespread moderate improvements in overall anemia prevalence but identify only three LMICs with a high probability of achieving the WHO GNT by 2030 at a national scale, and no LMIC is expected to achieve the target in all their subnational administrative units. Our maps show where large within-country disparities occur, as well as areas likely to fall short of the WHO GNT, offering precision public health tools so that adequate resource allocation and subsequent interventions can be targeted to the most vulnerable populations.
AB - Anemia is a globally widespread condition in women and is associated with reduced economic productivity and increased mortality worldwide. Here we map annual 2000–2018 geospatial estimates of anemia prevalence in women of reproductive age (15–49 years) across 82 low- and middle-income countries (LMICs), stratify anemia by severity and aggregate results to policy-relevant administrative and national levels. Additionally, we provide subnational disparity analyses to provide a comprehensive overview of anemia prevalence inequalities within these countries and predict progress toward the World Health Organization’s Global Nutrition Target (WHO GNT) to reduce anemia by half by 2030. Our results demonstrate widespread moderate improvements in overall anemia prevalence but identify only three LMICs with a high probability of achieving the WHO GNT by 2030 at a national scale, and no LMIC is expected to achieve the target in all their subnational administrative units. Our maps show where large within-country disparities occur, as well as areas likely to fall short of the WHO GNT, offering precision public health tools so that adequate resource allocation and subsequent interventions can be targeted to the most vulnerable populations.
U2 - 10.1038/s41591-021-01498-0
DO - 10.1038/s41591-021-01498-0
M3 - Journal article
C2 - 34642490
SN - 1078-8956
VL - 27
SP - 1761
EP - 1782
JO - Nature Medicine
JF - Nature Medicine
ER -
